Why the study?
It was unknown whether a free-breathing mean heart dose of 4 Gy reliably selects left breast cancer patients after modified radical mastectomy for deep inspiration breath-hold, and whether anatomical indicators could predict this threshold.
Does deep inspiration breath-hold reduce heart dose in patients with left breast cancer undergoing PMRT/IMRT compared to free-breathing?
Does deep inspiration breath-hold reduce heart dose in patients with left breast cancer undergoing PMRT/IMRT compared to free-breathing?
An FB-MHD of 4 Gy is an efficient threshold for selecting left breast cancer patients for DIBH, and CCED can reliably predict this threshold at CT simulation.
DIBH associated with lower heart doses in left breast PMRT; supports CCED for FB-MHD threshold prediction but leaves open prospective validation.
Purpose: This study explored whether a free-breathing mean heart dose (FB-MHD) of 4 Gy is a reliable dose threshold for selecting left breast cancer patients after modified radical mastectomy suitable for deep inspiration breath-hold (DIBH) and developed anatomical indicators to predict FB-MHD for rapid selection. Materials and methods: Twenty-three patients with left breast cancer treated with DIBH were included to compare FB and DIBH plans. The patients were divided into the high-risk (FB-MHD ≥ 4 Gy) and low-risk (FB-MHD < 4 Gy) groups to compare dose difference, normal tissue complication probability (NTCP) and the DIBH benefits. Another 30 patients with FB only were included to analyze the capacity of distinguishing high-risk heart doses patients according to anatomical metrics, such as cardiac-to-chest Euclidean distance (CCED), cardiac-to-chest gap (CCG), and cardiac-to-chest combination (CCC). Results: All heart doses were significantly lower in patients with DIBH plans than in those with FB plans. Based on FB-MHD of 4 Gy cutoff, the heart dose, NTCP for cardiac death, and benefits from DIBH were significantly higher in the high-risk group than in the low-risk group. The CCED was a valid anatomical indicator with the largest area under the curve (AUC) of 0.83 and maintained 95 % sensitivity and 70 % specificity at the optimal cutoff value of 2.5 mm. Conclusions: An FB-MHD of 4 Gy could be used as an efficient dose threshold for selecting patients suitable for DIBH. The CCED may allow a reliable prediction of FB-MHD in left breast cancer patients at CT simulation.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: